CAR-T细胞疗法在治疗血液恶性肿瘤方面取得了显著成效，但在实体瘤治疗中，由于肿瘤免疫抑制微环境的影响，CAR-T细胞的增殖、持久性和杀伤功能受到限制，导致治疗效果不理想。GITR及其配体GITRL作为与T细胞功能调节密切相关的新型共刺激分子，能够增强T细胞 ...

Learn more about whether Alvotech or TG Therapeutics, Inc. is a better investment based on AAII's A+ Investor grades, which ...

Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, highlights activity at recent scientific conferences and announces participation in future events.

Kairos Pharma (NYSE American: KAPA) , a clinical-stage biopharmaceutical company, reported recent activity at major scientific gatherings and announc ...

Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, highlights activity at recent scientific conferences and announces participation in future events. Highlights ...

LOS ANGELES--(BUSINESS WIRE)--Kairos Pharma, Ltd. (NYSE American: KAPA), a clinical-stage biopharmaceutical company, highlights activity at recent scientific conferences and announces participation in ...

Astellas has said it will book a $170 million impairment charge in its fourth quarter results as a result of a decision to halt the development of three gene therapy candidates for Duchenne ...